Location History:
- Hyogo, JP (2009)
- Kyoto, JP (2012)
Company Filing History:
1 out of 71 
1 out of 378 
Years Active: 2009-2012
Title: Naoki Omori: Innovator in Pharmaceutical Chemistry
Introduction
Naoki Omori is a distinguished inventor based in Kyoto, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on fused azole-pyrimidine derivatives. With a total of 2 patents, his inventions are poised to impact the treatment of various diseases.
Latest Patents
Omori's latest patents focus on novel fused azole-pyrimidine derivatives. These compounds exhibit enhanced potency for phosphatidylinositol-3-kinase (PI3K) inhibition, especially for PI3K-γ inhibition. They can be utilized for the prophylaxis and treatment of diseases associated with PI3K activity, including inflammatory and immunoregulatory disorders such as asthma, atopic dermatitis, and chronic obstructive pulmonary disease (COPD). Additionally, these derivatives are relevant for treating cancer, heart failure, and neurodegenerative disorders like Parkinson's and Alzheimer's diseases.
Career Highlights
Throughout his career, Naoki Omori has worked with prominent organizations, including Bayer Pharmaceuticals Corporation and Bayer Pharma Aktiengesellschaft. His experience in these companies has allowed him to refine his expertise in pharmaceutical innovations and contribute to groundbreaking research.
Collaborations
Omori has collaborated with notable colleagues, including Mitsuyuki Shimada and Toshiki Murata. These partnerships have further enriched his research and development efforts in the pharmaceutical field.
Conclusion
Naoki Omori's work in developing fused azole-pyrimidine derivatives showcases his commitment to advancing medical science. His contributions are expected to play a crucial role in the treatment of various diseases, highlighting the importance of innovation in pharmaceutical chemistry.